{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:56:23Z","timestamp":1792814183206,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>During the last decade, there has been a growing number of cases of children born from pregnancy-associated cancer (PAC), however there are currently insufficient data on the follow up to be observed in this category of newborns. Objective of the study was to evaluate the neonatal outcomes of infants born to mother with PAC, the potential adverse effect of chemotherapy during pregnancy and the risk of metastasis to the fetus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Maternal clinical data and neonatal outcomes of child born to mothers diagnosed with PAC were collected; infants were divided into those were and were not exposed to chemotherapy during fetal life and their outcomes were compered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 37 newborn infants from 36 women with PAC were analyzed. Preterm delivery occurred in 83.8% of the cases. No significant differences in neonatal outcomes were found between infants who were and were not exposed to chemotherapy during pregnancy. The median follow-up period was 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PAC treatment during the second or third trimester does not seem to be dangerous for the fetus, however infants born from PAC must be carefully evaluated for to rule out the consequences of chemotherapy and exclude the presence of metastasis. Long-term follow-up, especially in children exposed to chemotherapy, should be encouraged to obtain relevant data on long-term toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-023-06182-4","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T06:01:58Z","timestamp":1704261718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study"],"prefix":"10.1186","volume":"24","author":[{"given":"Michele Antonio","family":"Capozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Attin\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palma","family":"Maurizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"6182_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12884-017-1524-0","volume":"17","author":"K Melan","year":"2017","unstructured":"Melan K, Volumenie JL, Wan-Ajouhu G, Ulric-Gervaise S, Veronique-Baudin J, Joachim C. Pregnancy-associated-cancer in the French West Indies (Martinique): maternal and neonatal outcomes. BMC Pregnancy Childbirth. 2017;17:334.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6182_CR2","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","volume":"7","author":"NA Pavlidis","year":"2002","unstructured":"Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7:279\u201387.","journal-title":"Oncologist"},{"key":"6182_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1634\/theoncologist.2015-0362","volume":"21","author":"JE Rogers","year":"2016","unstructured":"Rogers JE, Dasari A, Eng C. The treatment of colorectal cancer during pregnancy: cytotoxic chemotherapy and targeted therapy challenges. Oncologist. 2016;21:563\u201370.","journal-title":"Oncologist"},{"key":"6182_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00404-002-0356-x","volume":"268","author":"C Jackisch","year":"2003","unstructured":"Jackisch C, Louwen F, Schwenkhagen A, Karbowski B, Schmid KW, Schneider HP, et al. Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet. 2003;268:69\u201377.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"6182_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1470-2045(18)30059-7","volume":"19","author":"J de Haan","year":"2018","unstructured":"de Haan J, Verheecke M, Van Calsteren K, Van Calster B, Shmakov RG, Mhallem Gziri M, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337\u201346.","journal-title":"Lancet Oncol"},{"key":"6182_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1517\/17425255.3.6.819","volume":"3","author":"J Behravan","year":"2007","unstructured":"Behravan J, Piquette-Miller M. Drug transport across the placenta, role of the ABC drug efflux transporters. Expert Opin Drug Metab Toxicol. 2007;3:819\u201330.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"6182_CR7","doi-asserted-by":"publisher","first-page":"e4899","DOI":"10.1097\/MD.0000000000004899","volume":"95","author":"S Esposito","year":"2016","unstructured":"Esposito S, Tenconi R, Preti V, Groppali E, Principi N. Chemotherapy against cancer during pregnancy: a systematic review on neonatal outcomes. Med (Baltim). 2016;95:e4899.","journal-title":"Med (Baltim)"},{"key":"6182_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1200\/JCO.1987.5.7.1098","volume":"5","author":"EE Reynoso","year":"1987","unstructured":"Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. JCO. 1987;5:1098\u2013106.","journal-title":"JCO"},{"key":"6182_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/COC.0000000000000527","volume":"42","author":"M La Nasa","year":"2019","unstructured":"La Nasa M, Gaughan J, Cardonick E. Incidence of neonatal neutropenia and leukopenia after in utero exposure to chemotherapy for maternal cancer. Am J Clin Oncol. 2019;42:351\u20134.","journal-title":"Am J Clin Oncol"},{"key":"6182_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/CCO.0000000000000386","volume":"29","author":"I Boere","year":"2017","unstructured":"Boere I, Lok C, Vandenbroucke T, Amant F. Cancer in pregnancy: safety and efficacy of systemic therapies. Curr Opin Oncol. 2017;29:328\u201334.","journal-title":"Curr Opin Oncol"},{"key":"6182_CR11","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3390\/cancers12123623","volume":"12","author":"AM Korakiti","year":"2020","unstructured":"Korakiti AM, Zografos E, van Gerwen M, Amant F, Dimopoulos MA, Zagouri F. Long-term neurodevelopmental outcome of children after in utero exposure to chemotherapy. Cancers (Basel). 2020;12:3623.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"6182_CR12","first-page":"00390","volume":"S2213\u20131779","author":"LW Liang","year":"2023","unstructured":"Liang LW, Lumish HS, Sewanan LR, Shimada YJ, Maurer MS, Weiner SD, et al. Advanced heart failure therapies for hypertrophic cardiomyopathy: state-of-the-art review and an updated analysis from UNOS. JACC Heart Fail. 2023;S2213\u20131779(23):00390\u20136.","journal-title":"JACC Heart Fail"},{"issue":"6","key":"6182_CR13","doi-asserted-by":"publisher","first-page":"e2113180","DOI":"10.1001\/jamanetworkopen.2021.13180","volume":"4","author":"M van Gerwen","year":"2021","unstructured":"van Gerwen M, Maggen C, Cardonick E, Verwaaijen EJ, van den Heuvel-Eibrink M, Shmakov RG, et al. Association of chemotherapy timing in pregnancy with congenital malformation. JAMA Netw Open. 2021;4(6):e2113180.","journal-title":"JAMA Netw Open"},{"key":"6182_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","volume":"39","author":"M Feghali","year":"2015","unstructured":"Feghali M, Venkataramanan R, Caritis S. Pharmacokinetics of drugs in pregnancy. Semin Perinatol. 2015;39:512\u20139.","journal-title":"Semin Perinatol"},{"key":"6182_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1701-2163(15)30999-3","volume":"35","author":"G Koren","year":"2013","unstructured":"Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V. Cancer chemotherapy and pregnancy. J Obstet Gynaecol Can. 2013;35:263\u201378.","journal-title":"J Obstet Gynaecol Can"},{"key":"6182_CR16","unstructured":"National Toxicology Program. NTP monograph: developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy. NTP Monogr. 2013;2:1\u2013214."},{"key":"6182_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","volume":"686","author":"H Dolk","year":"2010","unstructured":"Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol. 2010;686:349\u201364.","journal-title":"Adv Exp Med Biol"},{"key":"6182_CR18","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/cancers14133103","volume":"14","author":"S Triarico","year":"2022","unstructured":"Triarico S, Rivetti S, Capozza MA, Romano A, Maurizi P, Mastrangelo S, et al. Transplacental passage and fetal effects of antineoplastic treatment during pregnancy. Cancers (Basel). 2022;14:3103.","journal-title":"Cancers (Basel)"},{"key":"6182_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/wsbm.1212","volume":"5","author":"HM Rasouly","year":"2013","unstructured":"Rasouly HM, Lu W. Lower urinary tract development and disease. Wiley Interdiscip Rev Syst Biol Med. 2013;5:307\u201342.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"6182_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","volume":"28","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Heyns L, De Smet F, Van Eycken L, Gziri MM, Van Gemert W, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. JCO. 2010;28:683\u20139.","journal-title":"JCO"},{"key":"6182_CR21","doi-asserted-by":"publisher","first-page":"212608","DOI":"10.7573\/dic.212608","volume":"8","author":"A Ruggiero","year":"2019","unstructured":"Ruggiero A, Ariano A, Triarico S, Capozza MA, Ferrara P, Attin\u00e0 G. Neonatal pharmacology and clinical implications. Drugs Context. 2019;8:212608.","journal-title":"Drugs Context"},{"key":"6182_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022946","volume":"8","author":"NC Momen","year":"2018","unstructured":"Momen NC, Arendt LH, Ernst A, Olsen J, Li J, Gissler M, Ramlau-Hansen CH. Pregnancy-associated cancers and birth outcomes in children: a Danish and Swedish population-based register study. BMJ Open. 2018;8: e022946.","journal-title":"BMJ Open"},{"key":"6182_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-540-71274-9_16","volume":"178","author":"N Pavlidis","year":"2008","unstructured":"Pavlidis N, Pentheroudakis G. Metastatic involvement of placenta and foetus in pregnant women with cancer. Recent Results Cancer Res. 2008;178:183\u201394.","journal-title":"Recent Results Cancer Res"},{"key":"6182_CR24","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1200\/JCO.2003.12.149","volume":"21","author":"A Alexander","year":"2003","unstructured":"Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris RM, Zone JJ, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. JCO. 2003;21:2179\u201386.","journal-title":"JCO"},{"key":"6182_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","volume":"373","author":"F Amant","year":"2015","unstructured":"Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, et al. International Network on Cancer, Infertility, and Pregnancy (INCIP). Pediatric outcome after maternal cancer diagnosed during pregnancy. NEJM. 2015;373:1824\u201334.","journal-title":"NEJM"},{"key":"6182_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00404-012-2287-5","volume":"286","author":"ES Abdel-Hady","year":"2012","unstructured":"Abdel-Hady ES, Hemida RA, Gamal A, El-Zafarany M, Toson E, El-Bayoumi MA. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet. 2012;286:283\u20136.","journal-title":"Arch Gynecol Obstet"},{"key":"6182_CR27","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1002\/ijc.27560","volume":"131","author":"A Avil\u00e9s","year":"2012","unstructured":"Avil\u00e9s A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Intern J Cancer. 2012;131:2678\u201383.","journal-title":"Intern J Cancer"},{"key":"6182_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/cncr.22081","volume":"107","author":"KM Hahn","year":"2006","unstructured":"Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107:1219\u201326.","journal-title":"Cancer"},{"key":"6182_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/bjc.1992.21","volume":"65","author":"M Lishner","year":"1992","unstructured":"Lishner M, Zemlickis D, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and foetal outcome following Hodgkin\u2019s disease in pregnancy. Brit J Cancer. 1992;65:114\u20137.","journal-title":"Brit J Cancer"},{"key":"6182_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s13058-014-0500-0","volume":"16","author":"RK Murthy","year":"2014","unstructured":"Murthy RK, Theriault RL, Barnett CM, Hodge S, Ramirez MM, Milbourne A, et al. Outcomes of children exposed in utero to chemotherapy for breast cancer. Breast Cancer Res. 2014;16:500.","journal-title":"Breast Cancer Res"},{"key":"6182_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/COC.0b013e3181a44ca9","volume":"33","author":"E Cardonick","year":"2010","unstructured":"Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010;33:221\u20138.","journal-title":"Am J Clin Oncol"},{"key":"6182_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0889-8545(05)70007-3","volume":"25","author":"TE Buekers","year":"1998","unstructured":"Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am. 1998;25:323\u20139.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"6182_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000151759","volume":"95","author":"FE ten Udink","year":"2009","unstructured":"ten Udink FE, ten Hove CH, Nix WM, de Vries JI, van de Loosdrecht AA, van Elburg RM. Transient neonatal myelosuppression after fetal exposure to maternal chemotherapy. Case report and review of the literature. Neonatology. 2009;95:80\u20135.","journal-title":"Neonatology"},{"key":"6182_CR34","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1200\/JCO.2016.69.9439","volume":"35","author":"D Lu","year":"2017","unstructured":"Lu D, Ludvigsson JF, Smedby KE, Fall K, Valdimarsd\u00f3ttir U, Cnattingius S, et al. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. JCO. 2017;35:1522\u20139.","journal-title":"JCO"},{"key":"6182_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2020.07.004","volume":"138","author":"T Vandenbroucke","year":"2020","unstructured":"Vandenbroucke T, Verheecke M, van Gerwen M, Van Calsteren K, Halaska MJ, Fumagalli M, et al. International Network on Cancer, Infertility and Pregnancy (INCIP). Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy. Eur J Cancer. 2020;138:57\u201367.","journal-title":"Eur J Cancer"},{"key":"6182_CR36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/cancers12051266","volume":"12","author":"A Romano","year":"2020","unstructured":"Romano A, Capozza MA, Mastrangelo S, Maurizi P, Triarico S, Rolesi R, et al. Assessment and management of platinum-related ototoxicity in children treated for cancer. Cancers (Basel). 2020;12:1266.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"6182_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1086\/502454","volume":"25","author":"B Posteraro","year":"2004","unstructured":"Posteraro B, Bruno S, Boccia S, Ruggiero A, Sanguinetti M, Romano Spica V, et al. Candida parapsilosis bloodstream infection in pediatric oncology patients: results of an epidemiologic investigation. Infect Control Hosp Epidemiol. 2004;25(8):641\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6182_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, De Catte L, Chai DC, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119:594\u2013600.","journal-title":"Gynecol Oncol"},{"key":"6182_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/annonc\/mdf118","volume":"13","author":"LC Kremer","year":"2002","unstructured":"Kremer LC, van Dalen EC, Offringa M, Vo\u00fbte PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002;13:503\u201312.","journal-title":"Ann Oncol"},{"key":"6182_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.624057","volume":"11","author":"R Sofia","year":"2021","unstructured":"Sofia R, Melita V, De Vita A, Ruggiero A, Romano A, Attin\u00e0 G, et al. Cardiac surveillance for early detection of late subclinical cardiac dysfunction in childhood cancer survivors after anthracycline therapy. Front Oncol. 2021;11: 624057.","journal-title":"Front Oncol"},{"key":"6182_CR41","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/10428190802140873","volume":"49","author":"S Myrehaug","year":"2008","unstructured":"Myrehaug S, Pintilie M, Tsang R, Mackenzie R, Crump M, Chen Z, et al. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma. 2008;49:1486\u201393.","journal-title":"Leuk Lymphoma"},{"key":"6182_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12885-017-3772-9","volume":"17","author":"M Framarino-Dei-Malatesta","year":"2017","unstructured":"Framarino-Dei-Malatesta M, Sammartino P, Napoli A. Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus? BMC Cancer. 2017;17:777.","journal-title":"BMC Cancer"},{"key":"6182_CR43","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0140-6736(11)61092-1","volume":"379","author":"F Amant","year":"2012","unstructured":"Amant F, Loibl S, Neven P, Van Calsteren K. Breast cancer in pregnancy. Lancet. 2012;379:570\u20139.","journal-title":"Lancet"},{"key":"6182_CR44","doi-asserted-by":"publisher","first-page":"271363","DOI":"10.1155\/2008\/271363","volume":"2008","author":"DT Klink","year":"2008","unstructured":"Klink DT, van Elburg RM, Schreurs MW, van Well GT. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol. 2008;2008:271363.","journal-title":"Clin Dev Immunol"},{"key":"6182_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1470-2045(06)70797-5","volume":"7","author":"M Decker","year":"2006","unstructured":"Decker M, Rothermundt C, Holl\u00e4nder G, Tichelli A, Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell Lymphoma during second trimester of pregnancy. Lancet Oncol. 2006;7:693\u20134.","journal-title":"Lancet Oncol"},{"key":"6182_CR46","first-page":"1426","volume":"91","author":"B Friedrichs","year":"2006","unstructured":"Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica. 2006;91:1426\u20137.","journal-title":"Haematologica"},{"key":"6182_CR47","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/annonc\/mdz228","volume":"30","author":"F Amant","year":"2019","unstructured":"Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30:1601\u201312.","journal-title":"Ann Oncol"},{"key":"6182_CR48","volume-title":"International Classification of Diseases for Oncology (ICD-O-3)","author":"A Fritz","year":"2000","unstructured":"Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology (ICD-O-3). 3rd ed. Geneva: World Health Organization; 2000.","edition":"3"},{"key":"6182_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","volume":"51","author":"E Bertino","year":"2010","unstructured":"Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-06182-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06182-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T06:04:57Z","timestamp":1704261897000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-06182-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6182"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-06182-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3151801\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"8 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Fondazione Policlinico Agostino Gemelli IRCCS (protocol code DIPUSVSP-25\u201306-2163). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent has been obtained from the parents and\/or legal guardians to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}